Areteia Therapeutics Inc.
Areteia Therapeutics is developing the first oral drug for eosinophilic asthma.
Company Location
101 Glen Lennox Drive, Suite 300
Chapel Hill
NC
27517
County
Region
Company Details
Company type
Year founded
2022
Employment range in NC
US headquarters
North Carolina
Global headquarters
United States
Primary site activity
All company activities
Potential end market(s)